Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs.

Current opinion in pharmacology - 1 Oct 2011

Pasipanodya Jotam G, Gumbo Tawanda

Abstract excerpt

The current understanding of the mechanism of anti-tuberculosis drug resistance has been shaped by the history of development of anti-tuberculosis drugs in the past 60 years and was arrived at as part of inductive generalization. Recently, these standard beliefs have been tested in controlled hollow fiber systems experiments. Drug resistance in Mycobacterium tuberculosis was shown to be related to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Medication Adherence

Share to Mutation

Share to Mycobacterium tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 21807559
DOI: 10.1016/j.coph.2011.07.001
PMCID: PMC3183135

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs.PMID 21807559Read ↗

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and TherapySemantic proximity Read ↗

What are the origins of growing microbial resistance? Both Lamarck and Darwin were right.Semantic proximity Read ↗

Drug-resistance mechanisms and tuberculosis drugs.Semantic proximity Read ↗

Human Tuberculosis II. M. tuberculosis Mechanisms of Genetic and Phenotypic Resistance to Anti-Tuberculosis Drugs.Semantic proximity Read ↗

Views on the sustenance of resistant Mycobacterium tuberculosis in the environment.Semantic proximity Read ↗

The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis.Semantic proximity Read ↗

Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.Semantic proximity Read ↗

Insights into the processes that drive the evolution of drug resistance in <i>Mycobacterium tuberculosis</i>Semantic proximity Read ↗

Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.Semantic proximity Read ↗

Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectivesSemantic proximity Read ↗

Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and TreatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.